Dow Down 1.39% Nasdaq Down 1.65%

Cancer Genetics, Inc. (CGIX)

-NasdaqCM
9.00 Up 0.00(0.00%) 3:35PM EDT - Nasdaq Real Time Price
Prev Close:9.00
Open:8.90
Bid:8.77 x 800
Ask:8.96 x 100
1y Target Est:18.58
Beta:N/A
Next Earnings Date:N/A
Day's Range:8.77 - 9.08
52wk Range:8.25 - 22.59
Volume:37,220
Avg Vol (3m):47,488
Market Cap:87.26M
P/E (ttm):N/A
EPS (ttm):-1.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CGIX

Comparison

Symbol% ChgMkt Cap
CGIXUp 0.00%87.26M
GHDXUp 0.92%900.73M
MYGNDown 1.48%2.77B
RGDXDown 2.19%25.95M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.42
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.65
Quarterly EPS Est (Sep-14) :-0.48
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-0.14

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cancer Genetics, Inc., an early-stage diagnostics company, focuses on developing and commercializing proprietary genomic tests and services to improve and personalize the diagnosis, prognosis, and response to treatment of cancer. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback